ClinicalTrialsFinder

Recurrent Platinum-Resistant Ovarian Carcinoma Clinical Trials in Baltimore, Maryland

1 recruitingBaltimore, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 1

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Metastatic Endometrial CarcinomaStage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8+8 more
National Cancer Institute (NCI)42 enrolled6 locationsNCT05691504